When the National Diabetes Prevention Program (DPP) became covered under the Affordable Care Act, it brought DPP to millions of at-risk Americans, and brought a mountain of work to healthcare providers newly eligible to be compensated by health plans. Patient identification, referrals, electronic claims, auditing, fraud prevention, and compliance loomed as prohibitive undertakings for small providers.
Solera was created as a technology platform that links healthcare providers to patients and their health plans. Solera handles the “back office” chores of healthcare providers, acting as a single point of contact to Medicare and other health plans, which allows providers to focus on what they do best: provide care.
Solera helps consolidate a range of programs and services into an integrated digital network that allows health plans and medical providers to lower costs and increase consumer participation. Solera also identifies the “best fit” chronic disease prevention program provider based on an individual’s needs to increase patient outcomes and decrease costs. Finally, Solera leverages big data through predictive analytics algorithms that help payers to find enrollees who are likely pre-diabetic and get them into DPP, helping to decrease both costs for payers and incidents of diabetes for patients.
Learn more about Solera Health here.
Sources:
1. Solera
2. American Journal of Managed Care
Disclosure: Abacus Wealth Partners, LLC (Abacus) is an SEC registered investment adviser with its principal place of business in the State of California. Abacus may only transact business in those states in which it is notice filed, or qualifies for an exemption or exclusion from notice filing requirements. This brochure is limited to the dissemination of general information pertaining to its investment advisory services. Any subsequent, direct communication by Abacus with a prospective client shall be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides. For information pertaining to the registration status of Abacus, please contact us or refer to the Investment Adviser Public Disclosure web site (www.adviserinfo.sec.gov).
This is not an offer to sell any type of security. This information is provided for educational purposes only and should not be considered investment advice or a solicitation to buy or sell this security. This newsletter contains general information that is not suitable for everyone. The information contained herein should not be construed as personalized investment advice. Information was based on sources we deem to be reliable, but we make no representations as to its accuracy. Past performance is no guarantee of future results. There is no guarantee that the views and opinions expressed in this newsletter will come to pass. Investing in the stock market involves gains and losses and may not be suitable for all investors. Information presented herein is subject to change without notice and should not be considered as a solicitation to buy or sell any security. Information related to the firm’s performance is based on pure model portfolios only and is net of fees. Certain clients may have holdings that deviate from the model and as such individual client performance may be different than the results presented herein.
For additional information about Abacus, including fees and services, send for our disclosure brochure as set forth on Form ADV from us using the contact information herein. Please read the disclosure brochure carefully before you invest or send money.
